4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-101674
Chief Development Officer sold 3,035 shares at $10.77 ($32,687)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kaiser Peter · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-24 | Sale : show line 1 in the form 10b5-1 | −3,035 | $10.77 | $32,687 | 264,378 | D |
| Open-market sales · 3,035 sh · avg $10.77 · $32,687 | ||||||
Loading xslF345X06/tm2624096-4_4seq1.xml…